ArticleJapanese journal of clinical oncology2025
Incidence, risk factors, and prognostic impact of regional lymph node metastasis in bone sarcoma: a population-based cohort study.
Article in Japanese journal of clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wide resection and reconstruction using the sandwich technique for primary undifferentiated pleomorphic sarcoma of the sternum: a case report.General thoracic and cardiovascular surgery cases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the risk factors and prognostic impact of regional lymph node metastasis (RLNM) in patients with bone sarcoma.
methodsThis retrospective study analyzed data from a Japanese registry of patients with bone sarcoma (2006-19). Disease-specific overall survival was estimated using the Kaplan-Meier method. A Cox regression model was used to identify risk factors for RLNM and prognostic factors.
resultsAmong 5064 patients, 157 (3.1%) had RLNM. The incidence varied by histological subtype: 7.6% in Ewing sarcoma, 3.1% in osteosarcoma, 1.6% in chondrosarcoma, and 5.2% in undifferentiated pleomorphic sarcoma. Higher rates were observed in rare subtypes, including mesenchymal chondrosarcoma (12.9%) and dedifferentiated chondrosarcomas (10.3%). Risk factors for RLNM included older age, tumor size (>8 cm) (P = .02), distant metastasis at diagnosis (P < .0001), skip metastasis (P < .0001), and histological subtype (e.g. Ewing sarcoma and dedifferentiated chondrosarcoma). RLNM was associated with poor prognosis (HR 1.69, 95% CI: 1.35-2.1, P < .0001), with isolated RLNM conferring survival outcomes equivalent to those with distant metastasis. Among RLNM cases, skip metastasis was the only significant independent predictor of poor prognosis (HR 2.41, 95% CI: 1.35-4.30, P = .003).
conclusionsThe incidence of RLNM in bone sarcomas varies by histological subtype. Risk factors include older age, tumor size, distant metastasis, skip metastasis, and histological subtype. Isolated RLNM has a prognosis comparable to that of distant metastases, and skip metastasis is a significant negative prognostic factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.